“An excellent overall experience. The access to decision makers to facilitate peer to peer contact and the two way flow of information is outstanding”
Shehnaaz Suliman, Director, Corporate Development Gilead Sciences

“Provides a relaxed informal environment in which approaches to other companies can be explored in a relatively open and unconstrained fashion”
Robert Burns, Chief Executive Officer,Celldex

"Having attended over numerous years, I am always certain of having high level of interaction with fellow delegates".
Thomas Hofstaetter, Senior Vice President, Corporate Business Development, Wyeth

“This conference evolves with the ever-changing issues and needs of the biopharmaceutical companies attending”
John Siebert, Chariman and Chief Executive Officer, CyDex, Inc.

“The conference’s intimate and informal nature provides the context for senior level executives from both industry and emerging innovative companies to establish the necessary basis for partnering success.”
Brent Vaughan, Chief Business Officer, KineMed Inc.

“A very productive and enjoyable conference, representing one of the best opportunities to network with, and learn from, industry colleagues in a professional and relaxed environment.”
Paul Wotton, President & Chief Executive Officer, Topigen Pharmaceuticals Inc

“This prestiguous event offers a unique opportunity to meet with key executives both from Biotech and Pharma in a frequency you rarely see in any other biopharmaceutical conference.”
Peter Heinrich, Chief Executive Officer, MediGene AG

“This conference is one of the most productive events of its type. The ability to confer and discuss business opportunities with senior pharmaceutical executives is excellent.”
Julia Gregory, Executive Vice President, Corporate Development & Chief Financial Officer, Lexicon Genetics Inc

“Excellently balanced – platform sessions vs networking vs social interaction”
Dr Andrew Heath, Chief Executive Officer, Protherics plc

“Business gets done through relationships and this meeting helps develop deep relationships”
Donald deBethizy, President & CEO, Targacept, Inc

“A good opportunity to meet leaders of biotech companies and discuss potential partnering opportunities”
Ms Barbara Yanni, Vice President & Chief Licensing Officer, Merck & Co, Inc

“The one conference I make sure I put on my calendar. Great opportunity to meet the people you want to do business with”
James Karis, President & Chief Executive Officer, Entelos

“A more intimate meeting with senior level attendance”
Gwen Melincoff, Vice President Business Development, Shire Pharmaceuticals

“A highly organised and enjoyable conference, - very worthwhile, with the right level of participants”
Harry Stratford, Executive Chairman, ProStraken Group plc

Design (rm) ripe media